Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose ...
The prescription of high dose was associated with an increased risk of TD, and the highest risk was observed in the group receiving >300 mg/day.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback